These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7776796)

  • 1. Treatment of late Lyme borreliosis with cefoperazone and sulbactam.
    Gasser RN; Reisinger EC; Eber B; Wendelin I; Pokan R; Seinost G; Klein W
    Lancet; 1995 Mar; 345(8949):586. PubMed ID: 7776796
    [No Abstract]   [Full Text] [Related]  

  • 2. Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific beta-lactamase inhibition.
    Gasser R; Reisinger E; Eber B; Pokan R; Seinost G; Berglöff J; Horwarth R; Sedaj B; Klein W
    Microb Drug Resist; 1995; 1(4):341-4. PubMed ID: 9158807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients.
    Winston DJ; Bartoni K; Bruckner DA; Schiller GJ; Territo MC
    Clin Infect Dis; 1998 Mar; 26(3):576-83. PubMed ID: 9524826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cefoperazone/sulbactam in neonates.
    Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
    Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
    Bodey G; Abi-Said D; Rolston K; Raad I; Whimbey E
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):625-34. PubMed ID: 8894569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
    Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
    Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis.
    Dressler F; Ackermann R; Steere AC
    J Infect Dis; 1994 Feb; 169(2):313-8. PubMed ID: 8106763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A trial of using sulperazone (cefoperazone/sulbactam) in the combined treatment of patients with a burn infection].
    Iakovlev VP; Krutikov MG; Alekseev AA; Grishina IA; Izotova GN; Kashin IuD
    Antibiot Khimioter; 1995 May; 40(5):38-41. PubMed ID: 8534180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefoperazone/sulbactam + co-trimoxazole vs ceftazidime + co-trimoxazole in the treatment of severe melioidosis: a randomized, double-blind, controlled study.
    Thamprajamchit S; Chetchotisakd P; Thinkhamrop B
    J Med Assoc Thai; 1998 Apr; 81(4):265-71. PubMed ID: 9623020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune response to Borrelia burgdorferi in patients with Lyme borreliosis.
    Krause A; Rensing A; Kalden JR; Burmester GR
    Behring Inst Mitt; 1991 Feb; (88):52-8. PubMed ID: 2049046
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
    Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
    Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endemic threat of Lyme borreliosis in Bialowicza forestry area].
    Flisiak R; Prokopowicz D; Flisiak I; Bobrowska E; Miegoć H; Grzeszczuk A; Sulik E; Okolów C
    Przegl Epidemiol; 1994; 48(3):211-7. PubMed ID: 7938624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis.
    Suttorp-Schulten MS; Kuiper H; Kijlstra A; van Dam AP; Rothova A
    Am J Ophthalmol; 1993 Nov; 116(5):571-5. PubMed ID: 8238216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyme borreliosis among Danish patients with arthritis.
    Kryger P; Hansen K; Vinterberg H; Pedersen FK
    Scand J Rheumatol; 1990; 19(1):77-81. PubMed ID: 2309106
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Fournier MA
    J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections.
    Jauregui LE; Appelbaum PC; Fabian TC; Hageage G; Strausbaugh L; Martin LF
    J Antimicrob Chemother; 1990 Mar; 25(3):423-33. PubMed ID: 2187014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Toyama K; Torii Y; Aoki I; Kikuchi M; Wakasugi K
    Jpn J Antibiot; 1992 Aug; 45(8):1003-8. PubMed ID: 1433888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.
    Choi JY; Kim CO; Park YS; Yoon HJ; Shin SY; Kim YK; Kim MS; Kim YA; Song YG; Yong D; Lee K; Kim JM
    Yonsei Med J; 2006 Feb; 47(1):63-9. PubMed ID: 16502486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of the 3M Fast-Lyme test in the early diagnosis of borreliosis].
    Borowska SC; Szymański W; Rogalewska A; Michalska I; Kowal K
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():65-8. PubMed ID: 1843813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.